United Therapeutics CEO Martine A. Rothblatt disposes of 8,500 common shares worth $4.53 million - UTHR News | RalliesUnited Therapeutics CEO Martine A. Rothblatt disposes of 8,500 common shares worth $4.53 million
U
UTHR• Stock option exercise and share sale
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42 on July 22, 2026.
- The trust then sold 9,500 shares in the market at weighted-average prices from $524.27 to $539.47.
- Trust holdings in common stock ended at 324,443 shares following the transactions.
- Stock options held by a trust fell to 293,910 following the exercise.
•
